News
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The FDA recommended different standards of evidence for approval based on patients' risk of getting severely sick from Covid.
A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...
The FDA is tightening Covid-19 vaccine approval, demanding stronger clinical proof for healthy individuals while easing ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results